Back to search results
NCT06823024

Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions

Enrolling by Invitation
Not specifiedAges 18–68Observational
Psyrin Inc.
~200 participants
Updated 2025-03-18 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Treatment response
Measured over Change between Baseline and Week 0 (post-intervention)

Conditions

Obsessive Compulsive Disorder (OCD)
Bipolar Disorders
Major Depressive Disorder
Post-Traumatic Stress Disorder, PTSD
Generalized Anxiety Disorder (GAD)

Explore related trials

Bipolar DisorderGeneralized Anxiety DisorderObsessive Compulsive DisorderPost-Traumatic Stress DisorderUnipolar Depression

Where it's being run

2 sites across 2 states
California1
New York1

Study leadership

  • Julianna Olah, B.Sc., M.A., M.Sc., Ph.D. · STUDY_DIRECTOR · Psyrin Inc.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Treatment responseChange between Baseline and Week 0 (post-intervention)

    ≥ 2 points symptom severity reduction between baseline and after-treatment evaluation on the clinical global impression severity scale (CGI-S) (between 1, normal, not at all ill, and 7, among the most extremely ill patients).